The study will use data to track insurance coverage as well as prior authorization requirements for GLP-1 drugs such as Ozempic and Zepbound.
Judge blocks Trumps latest pause on a major offshore wind farm
...
Read moreDetailsHome » Ro partners with Amgen to study barriers to obesity care, GLP-1 access
The study will use data to track insurance coverage as well as prior authorization requirements for GLP-1 drugs such as Ozempic and Zepbound.